|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aletti GD, Gallenberg MM, Cliby WA, Jatoi
A and Hartmann LC: Current management strategies for ovarian
cancer. Mayo Clin Proc. 82:751–770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morrison J: Advances in the understanding
and treatment of ovarian cancer. J Br Menopause Soc. 11:66–71.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bakrin N, Bereder JM, Decullier E, Classe
JM, et al: FROGHI (French Oncologic and Gynecologic HIPEC) Group:
Peritoneal carcinomatosis treated with cytoreductive surgery and
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced
ovarian carcinoma: a French multicentre retrospective cohort study
of 566 patients. Eur J Surg Oncol. 39:1435–1443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coleman RL, Monk BJ, Sood AK and Herzog
TJ: Latest research and treatment of advanced-stage epithelial
ovarian cancer. Nat Rev Clin Oncol. 10:211–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Werb Z: ECM and cell surface proteolysis:
regulating cellular ecology. Cell. 91:439–442. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Talvensaari-Mattila A, Santala M, Soini Y
and Turpeenniemi-Hujanen T: Prognostic value of matrix
metalloproteinase-2 (MMP-2) expression in endometrial endometrioid
adenocarcinoma. Anticancer Res. 25:4101–4105. 2005.PubMed/NCBI
|
|
8
|
Rowe RG and Weiss SJ: Navigating ECM
barriers at the invasive front: the cancer cell-stroma interface.
Annu Rev Cell Dev Biol. 25:567–595. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deakin NE and Chaplain MA: Mathematical
modeling of cancer invasion: the role of membrane-bound matrix
metalloproteinases. Front Oncol. 3:702013.PubMed/NCBI
|
|
10
|
Chen WT, Kelly T and Ghersi G: DPPIV,
seprase and related serine peptidases in multiple cellular
functions. Curr Top Dev Biol. 54:207–232. 2003.PubMed/NCBI
|
|
11
|
Goscinski MA, Suo ZH, Nesland JM, Flørenes
VA and Giercksky KE: Dipeptidyl peptidase IV expression in cancer
and stromal cells of human esophageal squamous cell carcinomas,
adenocarcinomas and squamous cell carcinoma cell lines. APMIS.
116:823–831. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mentlein R, Hattermann K, Hemion C,
Jungbluth AA and Held-Feindt J: Expression and role of the cell
surface protease seprase/fibroblast activation protein-α (FAP-α) in
astroglial tumors. Biol Chem. 392:199–207. 2011.PubMed/NCBI
|
|
13
|
Benedet JL, Bender H, Jones H III, Ngan HY
and Pecorelli S: FIGO staging classifications and clinical practice
guidelines in the management of gynecologic cancers. FIGO Committee
on Gynecologic Oncology. Int J Gynaecol Obstet. 70:209–262. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Q, Suo Z, Risbegr B, Karlsson MG,
Villman K and Nesland JM: Expression of EPhb2 And Ephb4 in Berast
Caerinoma. Phatol oneol Res. 10:26–33. 2004.
|
|
15
|
Lawrie LC, Curran S, MeLeod HL, Fothergill
JE and Murray GI: Applieation of laser capture microdissection and
porteomics in colon cancer. Mol Pathol. 54:253–258. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Monsky WL, Lin CY, Aoyama A, Kelly T,
Akiyama SK, Mueller SC and Chen WT: A potential marker protease of
invasiveness, seprase, is localized on invadopodia of human
malignant melanoma cells. Cancer Res. 54:5702–5710. 1994.PubMed/NCBI
|
|
17
|
Chen WT and Kelly T: Seprase complexes in
cellular invasiveness. Cancer Metastasis Rev. 22:259–269. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kotacková L, Baláziová E and Sedo A:
Expression pattern of dipeptidyl peptidase IV activity and/or
structure homologues in cancer. Folia Biol (Praha). 55:77–84.
2009.PubMed/NCBI
|
|
19
|
Pro B and Dang NH: CD26/dipeptidyl
peptidase IV and its role in cancer. Histol Histopathol.
19:1345–1351. 2004.PubMed/NCBI
|
|
20
|
Mueller SC, Ghersi G, Akiyama SK, Sang QX,
Howard L, Pineiro-Sanchez M, et al: A novel protease-docking
function of integrin at invadopodia. J Biol Chem. 274:24947–24952.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Brien P and O'Connor BF: Seprase: an
overview of an important matrix serine protease. Biochim Biophys
Acta. 1784:1130–1145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelly T, Kechelava S, Rozypal TL, West KW
and Korourian S: Seprase, a membrane-bound protease, is
overexpressed by invasive ductal carcinoma cells of human breast
cancers. Mod Pathol. 11:855–863. 1998.PubMed/NCBI
|
|
23
|
Jin X, Iwasa S, Okada K, Mitsumata M and
Ooi A: Expression patterns of seprase, a membrane serine protease,
in cervical carcinoma and cervical intraepithelial neoplasm.
Anticancer Res. 23:3195–3198. 2003.PubMed/NCBI
|
|
24
|
Okada K, Chen WT, Iwasa S, Jin X, Yamane
T, Ooi A and Mitsumata M: Seprase, a membrane-type serine protease,
has different expression patterns in intestinal- and diffuse-type
gastric cancer. Oncology. 65:363–370. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wikberg ML, Edin S, Lundberg IV, Van
Guelpen B, Dahlin AM, Rutegård J, et al: High intratumoral
expression of fibroblast activation protein (FAP) in colon cancer
is associated with poorer patient prognosis. Tumour Biol.
34:1013–1020. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Y, Wang S and Kelly T: Seprase
promotes rapid tumor growth and increased microvessel density in a
mouse model of human breast cancer. Cancer Res. 64:2712–2716. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ariga N, Sato E, Ohuchi N, Nagura H and
Ohtani H: Stromal expression of fibroblast activation
protein/seprase, a cell membrane serine proteinase and gelatinase,
is associated with longer survival in patients with invasive ductal
carcinoma of breast. Int J Cancer. 95:67–72. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wilson MJ, Ruhland AR, Quast BJ, Reddy PK,
Ewing SL and Sinha AA: Dipeptidylpeptidase IV activities are
elevated in prostate cancers and adjacent benign hyperplastic
glands. J Androl. 21:220–226. 2000.PubMed/NCBI
|
|
29
|
Khin EE, Kikkawa F, Ino K, Kajiyama H,
Suzuki T, Shibata K, et al: Dipeptidyl peptidase IV expression in
endometrial endometrioid adenocarcinoma and its inverse correlation
with tumor grade. Am J Obstet Gynecol. 188:670–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mizokami Y, Kajiyama H, Shibata K, Ino K,
Kikkawa F and Mizutani S: Stromal cell-derived
factor-1alpha-induced cell proliferation and its possible
regulation by CD26/dipeptidyl peptidase IV in endometrial
adenocarcinoma. Int J Cancer. 110:652–659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Abe M, Havre PA, Urasaki Y, Ohnuma K,
Morimoto C, Dang LH and Dang NH: Mechanisms of confluence-dependent
expression of CD26 in colon cancer cell lines. BMC Cancer.
11:512011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miyake Y, Aratake Y, Sakaguchi T, Kiyoya
K, Kuribayashi T, Marutsuka K and Ohno E: Examination of
CD26/DPPIV, p53 and PTEN expression in thyroid follicular adenoma.
Diagn Cytopathol. 40:1047–1053. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kajiyama H, Kikkawa F, Suzuki T, Shibata
K, Ino K and Mizutani S: Prolonged survival and decreased invasive
activity attributable to dipeptidyl peptidase IV overexpression in
ovarian carcinoma. Cancer Res. 62:2753–2757. 2002.PubMed/NCBI
|
|
34
|
Kennedy A, Dong H, Chen D and Chen WT:
Elevation of seprase expression and promotion of an invasive
phenotype by collagenous matrices in ovarian tumor cells. Int J
Cancer. 124:27–35. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lai D, Ma L and Wang F: Fibroblast
activation protein regulates tumor-associated fibroblasts and
epithelial ovarian cancer cells. Int J Oncol. 41:541–550.
2012.PubMed/NCBI
|
|
36
|
Yang L, Ma L and Lai D: Over-expression of
fibroblast activation protein alpha increases tumor growth in
xenografts of ovarian cancer cells. Acta Biochim Biophys Sin
(Shanghai). 45:928–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
